Starpharma Holdings Limited (FRA:PQ6)

Starpharma Holdings Statistics

Total Valuation

FRA:PQ6 has a market cap or net worth of EUR 122.23 million. The enterprise value is 111.75 million.

Market Cap	122.23M
Enterprise Value	111.75M

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	419.92M
Shares Outstanding	n/a
Shares Change (YoY)	+0.85%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	359.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.76
PB Ratio	10.02
P/TBV Ratio	10.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-60.88
EV / Sales	12.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-178.82

Financial Position

The company has a current ratio of 5.26, with a Debt / Equity ratio of 0.04.

Current Ratio	5.26
Quick Ratio	4.86
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.72
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.47% and return on invested capital (ROIC) is -8.43%.

Return on Equity (ROE)	-14.47%
Return on Assets (ROA)	-7.24%
Return on Invested Capital (ROIC)	-8.43%
Return on Capital Employed (ROCE)	-14.99%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	207,045
Profits Per Employee	-45,889
Employee Count	40
Asset Turnover	0.52
Inventory Turnover	4.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +429.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+429.63%
50-Day Moving Average	0.21
200-Day Moving Average	0.12
Relative Strength Index (RSI)	64.68
Average Volume (20 Days)	39

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:PQ6 had revenue of EUR 8.28 million and -1.84 million in losses. Loss per share was -0.00.

Revenue	8.28M
Gross Profit	2.45M
Operating Income	-1.84M
Pretax Income	-1.84M
Net Income	-1.84M
EBITDA	-1.68M
EBIT	-1.84M
Loss Per Share	-0.00

Balance Sheet

The company has 10.37 million in cash and 448,801 in debt, with a net cash position of 9.92 million.

Cash & Cash Equivalents	10.37M
Total Debt	448,801
Net Cash	9.92M
Net Cash Per Share	n/a
Equity (Book Value)	12.20M
Book Value Per Share	0.03
Working Capital	11.15M

Cash Flow

In the last 12 months, operating cash flow was -484,024 and capital expenditures -140,890, giving a free cash flow of -624,914.

Operating Cash Flow	-484,024
Capital Expenditures	-140,890
Free Cash Flow	-624,914
FCF Per Share	n/a

Margins

Gross margin is 29.59%, with operating and profit margins of -22.16% and -22.16%.

Gross Margin	29.59%
Operating Margin	-22.16%
Pretax Margin	-22.16%
Profit Margin	-22.16%
EBITDA Margin	-20.32%
EBIT Margin	-22.16%
FCF Margin	n/a

Dividends & Yields

FRA:PQ6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.85%
Shareholder Yield	-0.85%
Earnings Yield	-1.50%
FCF Yield	-0.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:PQ6 has an Altman Z-Score of -3.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.27
Piotroski F-Score	4